Rankings
▼
Calendar
TARA Q2 2016 Earnings — Protara Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
TARA
Protara Therapeutics, Inc.
$212M
Q2 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$8M
Net Income
-$8M
EPS (Diluted)
$-19.29
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$6M
Stock-Based Comp.
$946,000
Balance Sheet
Total Assets
$56M
Total Liabilities
$5M
Stockholders' Equity
$51M
Cash & Equivalents
$34M
← FY 2016
All Quarters
Q3 2016 →